Invention Grant
- Patent Title: Humanized or chimeric CD3 antibodies
-
Application No.: US15110414Application Date: 2015-01-08
-
Publication No.: US10407501B2Publication Date: 2019-09-10
- Inventor: Edward Norbert Van Den Brink , Joost J. Neijssen , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Isil Altintas , Paul Parren , Rik Rademaker
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DK201400009 20140109; WOPCT/EP2014/050340 20140109; WOPCT/EP2014/064326 20140704
- International Application: PCT/EP2015/050276 WO 20150108
- International Announcement: WO2015/104346 WO 20150716
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/10 ; C07K16/32 ; C07K16/42 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
Public/Granted literature
- US20160333095A1 HUMANIZED OR CHIMERIC CD3 ANTIBODIES Public/Granted day:2016-11-17
Information query
